Since Arrdc3 was more strongly enriched in the nutlin-3a-treated samples than the DMSO-treated samples, we chose to pursue the validation of Arrdc3 as a potential factor in TRP53-mediated tumour growth suppressing responses. This evidence concerns the gene ARRDC3 and neoplasm.